Spitzoid Melanoma — Trials

Spitzoid Melanoma — Trials · CancerIndex

Clinical trials

Registered studies

2 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 0
Recruiting: 0
Ph III recruiting: 0
Growth YoY: —
Industry share: —
Top sponsor: —
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (1)

clinicaltrialsPublishedShowing 1–2 of 2 studies · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04985604	Tovorafenib (DAY101) Monotherapy for Patients With Melanoma and Other Solid Tumors	terminated	Phase 2	23	Day One Biopharmaceuticals, Inc.INDUSTRY	7	Oct 2, 2025	clinicaltrials
NCT06680323	Identification of Risk Factors, Exposomics and Genetic Susceptibility of Melanoma in Children, Adolescents and Young Adults(ExpoMel)	recruiting	—	200	University Hospital TuebingenOTHER	5	Nov 8, 2024